BACKGROUND: Combining extinction training with cognitive-enhancing pharmacotherapy represents a novel strategy for improving the efficacy of exposure therapy for drug relapse prevention. We investigated if the selective glycine transporter-1 (GlyT-1) inhibitor RO4543338 could facilitate extinction of cocaine-conditioned responses and attenuate reacquisition of cocaine-seeking behavior. METHODS: Rats were trained to self-administer cocaine (0.3mg/kg), which was associated with a 2-s light cue under a second-order schedule of i.v. drug injection. Rats received vehicle, 30 or 45mg/kg of RO4543338 prior to three 1-h extinction-training sessions spaced at weekly intervals. Responses were extinguished by substituting saline for cocaine while maintaining response-contingent cue presentations. Reacquisition of cocaine-seeking behavior during self-administration sessions began 1 week after the last extinction session. Control experiments were conducted under conditions that precluded explicit extinction of cocaine-conditioned responses. RESULTS: Compared to vehicle, 30 and 45mg/kg RO4543338 significantly decreased responding early in extinction training and during subsequent reacquisition sessions. The latter effect persisted for at least five sessions. In control studies, reacquisition of cocaine-seeking behavior was not altered when RO4543338 was administered either prior to weekly self-administration control sessions or prior to weekly control sessions in which cocaine and cues were omitted and the levers retracted. CONCLUSIONS: As the GlyT-1 inhibitor facilitated cocaine-cue extinction learning and attenuated subsequent reacquisition of cocaine-seeking behavior, this class of compounds may have utility as a pharmacological adjunct to cocaine-cue exposure therapy in addicts.
BACKGROUND: Combining extinction training with cognitive-enhancing pharmacotherapy represents a novel strategy for improving the efficacy of exposure therapy for drug relapse prevention. We investigated if the selective glycine transporter-1 (GlyT-1) inhibitor RO4543338 could facilitate extinction of cocaine-conditioned responses and attenuate reacquisition of cocaine-seeking behavior. METHODS:Rats were trained to self-administer cocaine (0.3mg/kg), which was associated with a 2-s light cue under a second-order schedule of i.v. drug injection. Rats received vehicle, 30 or 45mg/kg of RO4543338 prior to three 1-h extinction-training sessions spaced at weekly intervals. Responses were extinguished by substituting saline for cocaine while maintaining response-contingent cue presentations. Reacquisition of cocaine-seeking behavior during self-administration sessions began 1 week after the last extinction session. Control experiments were conducted under conditions that precluded explicit extinction of cocaine-conditioned responses. RESULTS: Compared to vehicle, 30 and 45mg/kg RO4543338 significantly decreased responding early in extinction training and during subsequent reacquisition sessions. The latter effect persisted for at least five sessions. In control studies, reacquisition of cocaine-seeking behavior was not altered when RO4543338 was administered either prior to weekly self-administration control sessions or prior to weekly control sessions in which cocaine and cues were omitted and the levers retracted. CONCLUSIONS: As the GlyT-1 inhibitor facilitated cocaine-cue extinction learning and attenuated subsequent reacquisition of cocaine-seeking behavior, this class of compounds may have utility as a pharmacological adjunct to cocaine-cue exposure therapy in addicts.
Authors: Kimber L Price; Michael E Saladin; Nathaniel L Baker; Bryan K Tolliver; Stacia M DeSantis; Aimee L McRae-Clark; Kathleen T Brady Journal: Behav Res Ther Date: 2010-05-19
Authors: Elizabeth J Santa Ana; Bruce J Rounsaville; Tami L Frankforter; Charla Nich; Theresa Babuscio; James Poling; Kishorchandra Gonsai; Kevin P Hill; Kathleen M Carroll Journal: Drug Alcohol Depend Date: 2009-07-09 Impact factor: 4.492
Authors: Kimber L Price; Aimee L McRae-Clark; Michael E Saladin; Megan M Moran-Santa Maria; Stacia M DeSantis; Sudie E Back; Kathleen T Brady Journal: Am J Drug Alcohol Abuse Date: 2009 Impact factor: 3.829
Authors: Kathleen M Kantak; Yasmin Mashhoon; David N Silverman; Amy C Janes; Claudia M Goodrich Journal: Behav Brain Res Date: 2009-02-11 Impact factor: 3.332
Authors: Bríd A Nic Dhonnchadha; Jonathan J Szalay; Cindy Achat-Mendes; Donna M Platt; Michael W Otto; Roger D Spealman; Kathleen M Kantak Journal: Neuropsychopharmacology Date: 2010-01 Impact factor: 7.853
Authors: B Á Nic Dhonnchadha; B F Lovascio; N Shrestha; A Lin; K A Leite-Morris; H Y Man; G B Kaplan; K M Kantak Journal: Behav Brain Res Date: 2012-06-18 Impact factor: 3.332
Authors: Jamie M Gauthier; Amy Lin; Bríd Á Nic Dhonnchadha; Roger D Spealman; Heng-Ye Man; Kathleen M Kantak Journal: Addict Biol Date: 2015-09-18 Impact factor: 4.280
Authors: Kathleen M Kantak; Jamie M Gauthier; Elon Mathieson; Eudokia Knyazhanskaya; Pedro Rodriguez-Echemendia; Heng-Ye Man Journal: Behav Brain Res Date: 2020-08-02 Impact factor: 3.332
Authors: Margaret H Hastings; Jamie M Gauthier; Kyle Mabry; Audrey Tran; Heng-Ye Man; Kathleen M Kantak Journal: Behav Brain Res Date: 2020-03-16 Impact factor: 3.332
Authors: Cindy Achat-Mendes; Bríd Á Nic Dhonnchadha; Donna M Platt; Kathleen M Kantak; Roger D Spealman Journal: Neuropsychopharmacology Date: 2012-09-05 Impact factor: 7.853